Dosage Titration Planner
Select your medication and start date to generate a personalized week-by-week titration schedule based on FDA-approved prescribing information.
Your Titration Schedule
Weeks 1–4
Mar 24, 2026
through Apr 20, 2026
Weeks 5–8
Apr 21, 2026
through May 18, 2026
Weeks 9–12
May 19, 2026
through Jun 15, 2026
Weeks 13–16
Jun 16, 2026
through Jul 13, 2026
Week 17+
Jul 14, 2026
Ongoing maintenance
Note: If unable to tolerate dose escalation, may extend current dose by 4 additional weeks before increasing.
Schedule based on: Wegovy FDA Prescribing Information (2025)
How to Read Your Schedule
Select Medication
Choose the brand name medication you have been prescribed. Each drug has a different titration protocol from the FDA.
Enter Start Date
Enter the date of your first injection. The planner calculates all future dose change dates automatically.
Read the Timeline
Each row shows the dose step, the date range it covers, and whether it is a transitional or maintenance dose.
Print or Save
Use the Print Schedule button to print or save as PDF. Bring it to your provider appointment.
Important: Follow Your Provider's Instructions
This planner reflects the standard titration schedule from FDA prescribing information. Your provider may adjust your schedule based on tolerability, glycemic response, or individual factors. If you experience intolerable side effects, do not increase your dose — contact your prescriber. The FDA label for most GLP-1 medications allows extending any dose step by 4 additional weeks if needed before escalating.
Medical Disclaimer
This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations.
Always consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Do not disregard professional medical advice based on information found on this site.
No claims of therapeutic efficacy are made for substances that are not FDA-approved for the discussed indications. Research citations reflect published findings and do not imply endorsement.